Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Shares, $0.0001 par value per share
-
Shares outstanding
-
84.8M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
227K
-
Shares change
-
+122K
-
Total reported value, excl. options
-
$990K
-
Value change
-
+$574K
-
Number of buys
-
5
-
Number of sells
-
-2
-
Price
-
$4.35
Significant Holders of CITIUS ONCOLOGY, INC. - Common Shares, $0.0001 par value per share (CTOR) as of Q2 2025
8 filings reported holding CTOR - CITIUS ONCOLOGY, INC. - Common Shares, $0.0001 par value per share as of Q2 2025.
CITIUS ONCOLOGY, INC. - Common Shares, $0.0001 par value per share (CTOR) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 227K shares
of 84.8M outstanding shares and own 0.27% of the company stock.
Largest 8 shareholders include JANE STREET GROUP, LLC (107K shares), GEODE CAPITAL MANAGEMENT, LLC (57.3K shares), IFP Advisors, Inc (22.2K shares), UBS Group AG (15.4K shares), Arkadios Wealth Advisors (11.7K shares), BANK OF AMERICA CORP /DE/ (8.57K shares), OSAIC HOLDINGS, INC. (5.35K shares), and Yakira Capital Management, Inc. (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.